• Bone Marrow Transplant
• Leukemia & Other Myeloid Neoplasms

Bone Marrow Transplant

BMTIVBUCY

Myeloablative conditioning therapy prior to autologous and allogeneic hematopoietic stem cell transplantation for myeloid malignancies using IV busulfan and cyclophosphamide

• BMTIVBUCY Protocol
  

BMTLPDRIT

Pre-Emptive riTUXimab Therapy of Epstein-Barr Virus (EBV) Related Post-Transplant Lymphoproliferative Disease

• BMTLPDRIT Protocol

BMTMM0301

Conditioning therapy for autologous stem cell transplant using high dose melphalan in the treatment of multiple myeloma

• BMTMM0301 Protocol

MYHDC

Single dose cyclophosphamide priming therapy for multiple myeloma prior to autologous stem cell transplant.

• MYHDC Protocol

Top

Leukemia & Other Myeloid Neoplasms

ULKAMLAMTN

Maintenance Oral azaCITIDine for Acute Myeloid Leukemia

• ULKAMLAMTN Protocol
• ULKAMLAMTN Preprinted Order
• ULKAMLAMTN Patient Handout

LKAMLAS

Therapy of Acute Myeloid Leukemia Using azaCITIDine and SORAfenib

• LKAMLAS Protocol
• LKAMLAS Preprinted Order Pre-Transplant
• LKAMLAS Preprinted Order Post-Transplant

ULKAMLAVEN

Therapy of Acute Myeloid Leukemia using azaCITIDine and Venetoclax

• ULKAMLAVEN Protocol
• ULKAMLAVEN Preprinted Order Cycle 1
• ULKAMLAVEN Preprinted Order Cycle 2+

LKAMLCYT

Therapy of Acute Myeloid Leukemia Using Low dose Cytarabine

• LKAMLCYT Protocol
• LKAMLCYT Preprinted Order

LKAMLDCYT

Therapy of Acute Myeloid Leukemia using DAUNOrubicin Liposomal-Cytarabine Liposomal

• LKAMLDCYT Protocol

ULKAMLGIL

Therapy of Relapsed or Refractory FLT3+ Acute Myeloid Leukemia using Gilteritinib

• ULKAMLGIL Protocol
• ULKAMLGIL Preprinted Order

LKAMLMIDO

Therapy of FLT3+ Acute Myeloid Leukemia Using Midostaurin in Combination with Induction and Consolidation Chemotherapy

• LKAMLMIDO Protocol
• LKAMLMIDO Preprinted Order

LKANAG

Anagrelide as second-line treatment of thrombocytosis related to myeloproliferative disorders

• LKANAG Protocol

LKATOATRA

First-Line Induction and Consolidation Therapy of Acute Promyelocytic Leukemia Using Arsenic Trioxide and Tretinoin (All-Trans Retinoic Acid)

• LKATOATRA Protocol

LKATOP

First-Line Induction and Consolidation Therapy of Acute Promyelocytic Leukemia Using Arsenic Trioxide, Tretinoin (All-Trans Retinoic Acid) and DAUNOrubicin

• LKATOP Protocol

LKATOR

Induction and Consolidation Therapy of Relapsed Acute Promyelocytic Leukemia Using Arsenic Trioxide and Tretinoin (All-Trans Retinoic Acid)

• LKATOR Protocol

ULKBLIN

Treatment of Philadelphia Chromosome (Ph)-Positive or Ph-Negative Refractory or Relapsed Pre-B-Cell Acute Lymphoblastic Leukemia with Blinatumomab

• ULKBLIN Protocol

LKCMLA

Treatment of Chronic Myeloid Leukemia using Asciminib

• LKCMLA Protocol
  
• LKCMLA Preprinted Order
  

LKCMLB

Treatment of Chronic Myeloid Leukemia Using Bosutinib

• LKCMLB Protocol
• LKCMLB Preprinted Order

LKCMLI

Therapy for Chronic Myeloid Leukemia and Ph+ Acute Lymphoblastic Leukemia Using Imatinib

• LKCMLI Protocol
• LKCMLI Preprinted Order
• LKCMLI Patient Handout

LKCMLD

Treatment of Chronic Myeloid Leukemia and Ph+ Acute Lymphoblastic Leukemia Using Dasatinib

• LKCMLD Protocol
• LKCMLD Preprinted Order
• LKCMLD Patient Handout

LKCMLN

Treatment of Chronic Myeloid Leukemia Using Nilotinib

• LKCMLN Protocol
• LKCMLN Preprinted Order
• LKCMLN Patient Handout

ULKCMLP

Treatment of Chronic Myeloid Leukemia and Ph+ Acute Lymphoblastic Leukemia Using Ponatinib

• ULKCMLP Protocol
• ULKCMLP Preprinted Order
  

LKGEMOZ

Treatment of Acute Myeloid Leukemia Using Gemtuzumab Ozogamicin with Induction and Consolidation Chemotherapy

• LKGEMOZ Protocol

ULKINOZ

Treatment of Relapsed or Refractory Pre-B Cell Acute Lymphoblastic Leukemia with Inotuzumab Ozogamicin

• ULKINOZ Protocol
  

LKMDSA

Therapy of Myelodysplastic Syndrome using Azacitidine

• LKMDSA Protocol
• LKMDSA Preprinted Order

ULKMDSDC

Therapy of Myelodysplastic Syndrome using Decitabine-Cedazuridine

• ULKMDSDC Protocol
• ULKMDSDC Preprinted Order
• ULKMDSDC Patient Handout

LKMDSL

Therapy of Myelodysplastic Syndrome using Lenalidomide

• LKMDSL Protocol
• LKMDSL Preprinted Order

ULKMFFED

Treatment of Symptomatic Myelofibrosis with Fedratinib

• ULKMFFED Protocol
• ULKMFFED Preprinted Order

LKMFRUX

Treatment of Symptomatic Myelofibrosis with Ruxolitinib

• LKMFRUX Protocol
  
• LKMFRUX Preprinted Order
  

ULKMRDBLIN

Treatment of Pre-B-Cell Acute Lymphoblastic Leukemia with Minimal Residual Disease using Blinatumomab

• ULKMRDBLIN Protocol

LKPCVRUX

Treatment of Polycythemia Vera with Ruxolitinib

• LKPCVRUX Protocol
  
• LKPCVRUX Preprinted Order
  

LKPEGIFN

Peginterferon Alfa-2a Therapy of Chronic Myeloid Neoplasms and Hypereosinophilic Syndrome

• LKPEGIFN Protocol
  
• LKPEGIFN Preprinted Order

ULK0 Ropeginterferon alfa 2b

Interim Protocol for Ropeginterferon Alfa-2b Therapy of Chronic Myeloid Neoplasms and Hypereosinophilic Syndrome

• ULK0 Ropeginterferon alfa 2b Protocol
  
• ULK0 Ropeginterferon alfa 2b Preprinted Order
  

LYCODOXMR

Treatment of Burkitt’s Lymphoma and Leukemia (ALL-L3) with Cyclophosphamide, vinCRIstine, DOXOrubicin, Methotrexate, Leucovorin (CODOX-M) and riTUXimab

• see Lymphoma page

LYIVACR

Treatment of Burkitt’s Lymphoma and Leukemia (ALL-L3) with Ifosfamide, Mesna, Etoposide, Cytarabine (IVAC) and riTUXimab

• see Lymphoma page